Lipoprotein(a). Dieser Artikel ist nicht verfügbar.
Sprache: Englisch
Verlag: Palgrave Macmillan, 2023
- Hardcover
- Neu

Anbieter: AHA-BUCH GmbH, Einbeck, DeutschlandAHA-BUCH GmbH
Verkäufer:in bei ZVAB seit 14. August 2006
Zustand: Neu
EUR 258,46
Artikelbeschreibung des Verkäufers
nach der Bestellung gedruckt Neuware - Printed after ordering - Lipoprotein(a) [Lp(a)] is a unique lipoprotein that has emerged as an independentrisk factor for cardiovascular vascular disease.Data from case control, epigenetic and mendelian randomization studies indicate that people with elevated Lp(a) have a two-fold to four-fold increased risk of cardiovascular events compared to people with low Lp(a) levels.Despite this risk, awareness of Lp(a) is stillvery low among health care providers. Even cardiologistsoften overlookLp(a), in part because Lp(a) is not as well-understood as other risk factors and treatment options are still very limited.This book offers an authoritative and comprehensive overview ofLipoprotein(a). It provides an in-depthreview of all aspects of Lp(a), from pathophysiology to metabolism. Chapters offer the reader a contemporary view of the important roles of Lp(a) as a risk factor for cardiovascular disease. In addition, this volume discusses the clinical implications of elevated Lp(a) and current and future therapies.Lipoprotein(a)is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in lipidology, cardiology, endocrinology, pharmacotherapy, and health promotion and disease prevention.…
Bestandsnummer des Verkäufers 9783031245749
- Titel
- Lipoprotein(a)
- Autor
- Karam Kostner
- Verlag
- Palgrave Macmillan
- Erscheinungsjahr
- 2023
- Zustand
- Neu
- Einband
- Buch
- Sprache
- Englisch
- ISBN-10
- 3031245741
- ISBN-13
- 9783031245749
- Artikelgewicht
- 890 Gramm
- Abmessungen
- 241x160x29 mm
Lipoprotein(a) [Lp(a)] is a unique lipoprotein that has emerged as an independent risk factor for cardiovascular vascular disease. Data from case control, epigenetic and mendelian randomization studies indicate that people with elevated Lp(a) have a two-fold to four-fold increased risk of cardiovascular events compared to people with low Lp(a) levels. Despite this risk, awareness of Lp(a) is still very low among health care providers. Even cardiologists often overlook Lp(a), in part because Lp(a) is not as well-understood as other risk factors and treatment options are still very limited.
This book offers an authoritative and comprehensive overview of Lipoprotein(a). It provides an in-depth review of all aspects of Lp(a), from pathophysiology to metabolism. Chapters offer the reader a contemporary view of the important roles of Lp(a) as a risk factor for cardiovascular disease. In addition, this volume discusses the clinical implications of elevated Lp(a) and current and future therapies. Lipoprotein(a) is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in lipidology, cardiology, endocrinology, pharmacotherapy, and health promotion and disease prevention.„Inhaltsangabe“ gehört möglicherweise zu einer anderen Auflage dieses Titels.
Über die Autorin bzw. den Autor
Karam Kostner, MD, Ph.D., FRACP, FCSANZ
University of Queensland and Mater Hospital
Brisbane, AustraliaGerhard M. Kostner, Ph.D.
Medical University of Graz, Austria
Peter P. Toth, M.D. , PhD, FAHA, FESC, FACC
Adjunct Professor of Medicine
Division of Cardiology
Johns Hopkins University School of Medicine
Baltimore, Maryland USA
„Über diesen Titel“ gehört möglicherweise zu einer anderen Auflage dieses Titels.